UnknownPhase 4

Functional Improvement and UTC of the Achilles Tendon After Sodium Hyaluronate Injection for Plantaris Syndrome

United Kingdom33 participantsStarted 2017-03-20

Plain-language summary

This is a study to assess the benefit of sodium hyaluronate (Ostenil) injection for plantaris friction syndrome (PFS) associated with midportion Achilles tendinopathy. Functional outcome scores will be recorded prior to treatment and at regular intervals up to 2 years. Changes in tendon structure will be assessed using ultrasonographic tissue characterisation (UTC). UTC will be performed prior to treatment and also at regular intervals up to 6 months following injection.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18-75 years * Able to provide informed consent * Diagnosis of PFS requiring sodium hyaluronate injection * Able to follow physiotherapy instructions Exclusion Criteria: * Previous Achilles tendon surgery * Previous injection therapy for Achilles midportion tendinopathy * Age \< 18 \>75 years * Active local infection * Active bleeding disorder or anticoagulant therapy * Allergies to lignocaine or sodium hyaluronate * Active deep vein thrombosis

What they're measuring

Ultrasound Tissue Characterisation (UTC)

Timeframe: up to 6 months post intervention

Trial details

NCT IDNCT03077009

SponsorFortius Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-20

Contact for this trial

Mary Jones, MSc

44 (0) 203 195 2341 mary.jones@fortiusclinic.com

View on ClinicalTrials.gov More Plantaris Friction Syndrome trials